Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

06 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/06/3201046/35575/en/Aptose-s-Tuspetinib-Triple-Drug-Therapy-Featured-at-the-2025-ASH-Annual-Meeting-High-Rate-of-Frontline-Clinical-Responses-Continues-Across-AML-Populations.html

19 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/19/3190597/35575/en/Aptose-Biosciences-Announces-Arrangement-Agreement-for-Acquisition-by-Hanmi-Pharmaceutical.html

13 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/13/3187912/35575/en/Aptose-Reports-Third-Quarter-2025-Results.html

03 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/03/3179367/35575/en/Aptose-Tuspetinib-Clinical-Data-from-Ongoing-TUSCANY-Trial-in-Newly-Diagnosed-AML-Selected-for-Presentation-at-the-2025-ASH-Annual-Meeting.html

16 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/16/3167802/35575/en/Aptose-s-Tuspetinib-Exceeds-Expectations-When-Combined-with-Standard-of-Care-Treatment-Across-Diverse-Populations-of-Newly-Diagnosed-AML.html

22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3153823/35575/en/Aptose-and-Hanmi-Pharmaceutical-Extend-Loan-Agreement-to-Continue-Development-of-Tuspetinib-in-Triplet-Therapy-for-AML.html
ABOUT THIS PAGE